HSGXのニュース
Ocular Biotechs Histogenics (NASDAQ:HSGX), Ocugen Announce Stock-For-Stock Merger 2019/04/08 12:48:00 Benzinga
Histogenics Corporation (NASDAQ: HSGX) and privately held Ocugen announced a merger Monday that will create a new, Nasdaq-listed company aiming …
Helius Medical: A Failed Clinical Trial, Redacted Data, And Questionable Leadership, Points To An Ineffective Device 2019/01/29 10:00:00 Seeking Alpha
Ocular Biotechs Histogenics (NASDAQ:HSGX), Ocugen Announce Stock-For-Stock Merger 2019/04/08 12:48:00 Benzinga
Histogenics Corporation (NASDAQ: HSGX) and privately held Ocugen announced a merger Monday that will create a new, Nasdaq-listed company aiming …